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ABSTRACT
DNA transposases facilitate genome rearrange-
ments by moving DNA transposons around and
between genomes by a cut-and-paste mechanism.
DNA transposition proceeds in an ordered series of
nucleoprotein complexes that coordinate pairing
and cleavage of the transposon ends and integra-
tion of the cleaved ends at a new genomic site.
Transposition is initiated by transposase recogni-
tion of the inverted repeat sequences marking
each transposon end. Using a combination of solu-
tion scattering and biochemical techniques, we
have determined the solution conformations and
stoichiometries of DNA-free Mos1 transposase and
of the transposase bound to a single transposon
end. We show that Mos1 transposase is an
elongated homodimer in the absence of DNA and
that the N-terminal 55 residues, containing the first
helix-turn-helix motif, are required for dimerization.
This arrangement is remarkably different from the
compact, crossed architecture of the dimer in the
Mos1 paired-end complex (PEC). The transposase
remains elongated when bound to a single-
transposon end in a pre-cleavage complex, and
the DNA is bound predominantly to one transposase
monomer. We propose that a conformational
change in the single-end complex, involving rotation
of one half of the transposase along with binding of
a second transposon end, could facilitate PEC
assembly.
INTRODUCTION
Transposable elements are signiﬁcant components of most
eukaryotic genomes, shaping genome architecture and
gene regulatory networks (1,2). By moving from one
location to another, they can alter gene expression,
create mutations or promote genome evolution by
creating novel genes (3,4). DNA transposons of the
mariner/Tc1 family are particularly widespread in nature
(5) and are active in a broad range of species, including
vertebrates. Because of this, they are being exploited suc-
cessfully as tools for genetic engineering and gene delivery
(6,7).
Mariner/Tc1 elements move via a DNA intermediate, in
a cut-and-paste mechanism that brings the two ends of the
transposon together (Figure 1). The ends are separated by
1–2 kb and marked by inverted repeat (IR) DNA se-
quences. Transposition is orchestrated by a transposase
enzyme (encoded by the transposon sequence itself)
within an ordered series of nucleoprotein complexes.
Initially the speciﬁc sequence of the IR DNA is recognized
by the transposase DNA-binding domain. The two trans-
poson ends are then brought together, in a paired-end
complex (PEC), and precisely cleaved at the IRs before
being inserted at a new genomic site. DNA transposases
act as oligomers to bring the two transposon ends
together. This provides at least two catalytic sites for the
excision reactions at each end as well as the insertion re-
actions to covalently join the cleaved transposon to a new
target site. Various strategies for looping of DNA to
assemble the paired-end transposition complex are
possible (8). A pre-formed transposase oligomer can
bind to one transposon end before recruiting the second
naked end, as occurs during P-element transposition (9),
or the transposase can oligomerize after initially binding
separately to each IR or to just one IR.
The mechanism of transposition of the active mariner/
Tc1 transposon Mos1 (from Drosophila mauritiana) has
been studied from both biochemical and structural per-
spectives (10–14). The order and requirements for DNA
excision have been established (10,11), and crystal struc-
tures have been determined of the transposase C-terminal
catalytic domain (11) and the paired-end complex of
transposase and cleaved transposon DNA (14). The PEC
structure, representing the Mos1 transposition machinery
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after DNA cleavage and before transposon insertion into
target DNA, contains a transposase dimer bound to two
cleaved transposon ends in a crossed arrangement: each
28 bp IR sequence is recognized by the N-terminal DNA
binding of one transposase monomer and by the
C-terminal catalytic domain of the other monomer. The
bipartite DNA-binding domain contains two helix-turn-
helix (HTH) motifs. The N-terminal 55 residues (contain-
ing HTH1) also form part of the transposase dimerization
interface within the PEC (14).
The molecular events occurring earlier in the Mos1
transposition pathway, leading to PEC formation,
remain poorly understood. Mos1 transposase forms a
dimer in solution without DNA (11), and it has been
proposed that initially a transposase dimer binds rapidly
to one transposon end, in a single-end complex (SEC2)
(13,15); the N-terminal 35 residues were implicated in
cis-Mos1 transposase dimerization, leading to binding of
a single IR (12). The PEC could then form by recruitment
of the other naked IR to the complex. Divalent Mg2+ or
Mn2+ ions are required for PEC formation, as well as
DNA cleavage of mariner transposons (10,13,14,16,17).
The metal ions are coordinated by a triad of aspartic
acid residues in the RNase-H-like catalytic core of the
C-terminal catalytic domain (11). Metal ions may play
an additional role in stabilizing protein–DNA interactions
in the PEC and/or promoting the correct conformation of
this complex (15). It has been suggested that nicking of
one DNA strand can occur before pairing of the trans-
poson ends (10,16) and that this cleavage event may
promote a conformational change that facilitates PEC
assembly. However, this proposal is controversial; the
paradigm, established for bacterial DNA transposases, is
for pairing of transposon ends before DNA catalysis.
More recently Carpentier et al. (18) argued that PEC
assembly is indeed required for ﬁrst strand cleavage of
Mos1 inverted repeats.
We sought to establish the architecture of the full-length
Mos1 transposase prior to DNA binding, and the con-
formation of the pre-cleavage SEC2. Attempts to
crystallize the full-length transposase without DNA have
not been successful. However, solution scattering methods
can provide structural parameters and low resolution con-
formations of proteins and complexes. Neutron scattering
contrast variation in particular can distinguish the con-
formations and relative spatial arrangements of the con-
stituents of a nucleoprotein complex. This technique
exploits the signiﬁcantly different scattering length
densities of protein molecules compared with DNA, and
of hydrogen compared with deuterium (19). The contrast
between the solute and the solvent can be modulated by
altering the solvent D2O:H2O ratio. The contrast is
matched, at a particular D2O:H2O ratio, when the
scatter from a solute molecule equals that of the solvent;
the scattering from solute is therefore eliminated when the
scattering from the solvent is subtracted. Thus, it is
possible to mask the protein component of a complex,
so that only the DNA component contributes to the
overall scattering, and vice versa. Incorporation of deuter-
ium-labelled proteins in a complex extends the range of
contrasts available beyond those originally developed by
Stuhrman (20) and reduces the incoherent background
scatter from hydrogen in the sample. Dedicated facilities
for the production of deuterated macromolecules have
been developed within ILL’s Life Science Group (the
D-LAB), and there are now numerous examples
illustrating the power of deuteration approaches in small
angle neutron scattering (SANS) (21–24), neutron crystal-
lography (25) and dynamics (26).
Here we have combined complementary methods to
obtain low resolution solution structures of two early
molecular intermediates in Mos1 transpositon: Mos1 tran-
sposase and its pre-cleavage, single-end complex with
transposon DNA. We show that the DNA-free transpo-
sase homodimer adopts an extended conformation in
solution, in contrast to the more compact arrangement
Figure 1. Schematic of Mos1 transposition. The 1.3 kB transposon has
28 bp inverted repeats (IR) indicated with arrows. Binding of a
transposase dimer to one end forms a single-end complex (SEC2).
The transposon is fully excised from donor DNA in the paired-end
complex (PEC). Mariner/Tc1 transposons integrate at TA sequences,
resulting in signature duplications either side of the inserted
transposon.
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of the crossed dimer in the PEC crystal structure. The ﬁrst
55 residues of the transposase DNA-binding domain are
essential for dimerization. The elongated conformation is
slightly extended in the SEC2 formed under non-catalytic
conditions, and the DNA is bound predominantly to one
half of the transposase dimer. We propose that rotation of
the one transposase monomer about the DNA-binding
domain, coupled to binding of a second transposon
DNA end, could provide a mechanism to form the
compact PEC architecture previously determined by
X-ray crystallography.
MATERIALS AND METHODS
Expression and puriﬁcation of hydrogenated and
deuterated Mos1 transposases
Mos1 transposase (containing the solubilizing mutation
T216A), and hereafter referred to as H-Mos1, was ex-
pressed and puriﬁed as previously described (27).
Partially deuterated Mos1 transposase (D-Mos1) was ex-
pressed in Escherichia coli BL21(DE3) cells in minimal
medium (28) containing 85% (v/v) recycled D2O. Media
was inoculated with hydrogenated cell culture to 1% (v/v)
and incubated at 37C for 2–4 days. Protein expression
was induced at 30C with isopropylthiogalactoside
(1mM), and the cells were harvested after 5 h. D-Mos1
puriﬁcation was performed as described previously (27)
except that cation exchange was performed on a
SP-Sepharose FF column. The yield of D-Mos1 was
0.75mg per litre of culture. Proteins were stored at
20C in 25mM Tris pH 7.5, 250mM NaCl, 1mM
DTT and 50% (v/v) glycerol.
Mass spectrometry of deuterated Mos1 transposase
The mass of D-Mos1 was measured as 42 166 Da by
MALDI mass spectrometry. Thus, the level of deuterium
incorporation was 52.2% in H2O and 77.7% in D2O
(assuming exchange of all labile hydrogens and the loss
of the ﬁrst methionine in the sequence of the peptide).
Cloning of the N-terminal truncation mutant
delta-55 Mos1
The sequence coding for Mos1 transposase lacking the
N-terminal 55 amino acids was ampliﬁed from the full-
length Mos1 gene using forward (50-TACGTCATATGGG
CGATTTTGATGTGGATG-30) and reverse primers (50-T
ACGGCTCGAGTTATTCAAAGTACTTGCC-30), where
the restriction sites are underlined and the stop codon is in
italics. The 895bp PCR product was digested with NdeI and
XhoI enzymes (NEB), gel-puriﬁed and ligated (Rapid
Ligation Kit, Roche) with similarly digested, gel-puriﬁed
and de-phosphorylated pET30a or pET28a vector. The
integrities of the resulting clones (pET30-D55 and pET28-
D55) were conﬁrmed by Sanger sequencing.
Expression and puriﬁcation of deletion mutants
The delta-55 Mos1 mutant without a tag was expressed
from the pET30a-D55 plasmid. The 290 residue protein
(34.34 kDa) was puriﬁed by cation exchange and
gel-ﬁltration chromatography, as for full-length
transposase. The N-terminal 130 amino acids of Mos1
were expressed as previously described (29), and puriﬁed
by elution from an IMAC FF column (GE Healthcare)
with Imidazole, followed by cation exchange
chromatography. The N-terminal six His tag was
removed by thrombin cleavage (5 units/mg of puriﬁed
protein) in PBS at 17C for 16 h prior to gel-ﬁltration.
The resulting protein contained 133 amino acids (with a
molecular mass of 15.5 kDa).
Preparation of transposase samples for SANS
experiments
H-Mos1 and D-Mos1 protein samples were exchanged
multiple times (in a viva spin concentrator or by dialysis,
respectively) into fully hydrogenated and fully deuterated
buffers containing 25mM Tris (pH or pD 7.5), 350mM
KCl and 1mM DTT. Samples of D-Mos1 in buffer
containing 30% (v/v) D2O or 65% (v/v) D2O were then
prepared by mixing together appropriate volumes of D-
Mos1 in fully hydrogenated and fully deuterated buffer.
The concentration of each sample was calculated from
triplicate measurements of absorbance at 280 nm on a
Shimadzu UV-2401PC UV-Visible spectrophotometer.
DNA substrates
The DNA duplex for SEC2 was prepared by annealing
two complementary 50-mers containing the 28 base IR
sequence speciﬁcally recognized by transposase,
surrounded by 8 bases of transposon sequence and 14
bases of ﬂanking DNA. These had the sequences (50 ttt
aaa aa AAA CGA CAT TTC ATA CTT GTA CAC CTG
A tag ttt cta tat tc) and (50 gaa tat aga aac taT CAG GTG
TAC AAG TAT GAA ATG TCG TTT ttt tta aa), where
the IR sequence is in upper case. Oligonucleotides were
synthesized and PAGE puriﬁed by Integrated DNA
Technologies. Lyophilized samples were dissolved in
either H2O or D2O and annealed by heating molar
equivalents of complementary strands to 90C for 10min
and cooling to 25C in steps of 2C per 30 s.
Preparation of transposase DNA complexes
Single-end complexes were prepared by adding either
H-Mos1 or D-Mos1 to DNA in the molar ratio 2:1 in
20 ml aliquots. For contrast variation experiments, four
complexes were prepared, with different ratios of
H2O:D2O in the buffer. Two complexes (H-SEC2)
contained H-Mos1 and 0% (v/v) or 100% (v/v) D2O
and two contained D-Mos1 in buffers with 65% (v/v) or
100% (v/v) D2O (D-SEC2). Sample concentrations were
calculated from the average of three absorbance
measurements at 280 nm and 260 nm.
Gel-Filtration of transposase–DNA complexes
Samples were separated at room temperature on a
Superdex 200 10/300GL column (GE Healthcare). Iso-
cratic elution with buffer containing 20mM Tris pH 7.5,
0.3M KCl and 1mM DTT was monitored by absorbance
at 260 nm and 280 nm. Eluted fractions containing SEC2
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were loaded onto a 15% SDS-PAGE along with 6 internal
standards containing 150 ng, 300 ng or 450 ng of Mos1
transposase or DNA. The gel was silver-stained for
protein and DNA, and scanned using a BioRad GelDoc
EZImager (GE Healthcare). The intensity of bands was
quantiﬁed with EZImager using a uniform box size and
mean background subtraction.
Size-Exclusion Chromatography Multi-Angle Laser Light
Scattering (SEC-MALLS)
Themolar mass of transposases, duplex DNA and the SEC2
complex was determined by SEC-MALLS. Samples were
separated at room temperature on a Superdex 200 10/
300GL column linked to either an A¨KTA Ettan (GE
Healthcare) or Shimadzu HPLC system. The column was
pre-equilibrated with at least two column volumes of buffer
(as above). Elution was performed isocratically at 0.5ml/
min and monitored by absorbance at 280 nm. The HPLC
system was connected to a DAWNHELIOS IITM MALLS
instrument (Wyatt Technology) and Optilab T-rEX
refractometer (Wyatt Technology). On-line measurement
of the intensity of the Rayleigh scattering as a function of
the angle of the eluting peaks was used to determine the
weight average molecular masses (Mw) of the eluted
samples, using the ASTRATM (Wyatt Technologies)
software.
Small angle X-ray scattering (SAXS) data collection and
processing
SAXS data were collected at the European Synchrotron
Radiation Facility (ESRF) (beam line ID14-3,
=0.931 A˚) on a Pilatus 1 M detector. The sample to
detector distance was 2.43m, and scattering data were
collected within the momentum transfer (q) range
0.001–0.35 A˚1. To avoid radiation damage, the sample
(30 ml) was pushed through the capillary cell during data
collection. Data were collected in multiple 30 s frames,
inspected and averaged in PRIMUS(30) normalized to
the incident beam intensity and the scattering of the
buffer subtracted. To check for concentration-dependent
effects, scattering data were collected from H-Mos1
samples at 1.45mg/ml, 2.9mg/ml and 4.4mg/ml. SAXS
data were calibrated against bovine serum albumin (BSA)
at 5.6mg/ml. The molecular masses of the transposase and
the complex were calculated from the extrapolated
intensity at zero angle I(0), obtained with GNOM, by
comparison with the I(0) of BSA (molecular mass 66 kDa).
SANS data collection and processing
All SANS data were collected at the high neutron ﬂux
reactor at Institut Laue Langevin on beam line D22
equipped with a 3He Reuter-Stokes multi-detector.
Samples (minimum volume 200 ml) were placed in
1.0mm path length quartz cuvettes, sealed and transferred
to a sample changer maintained at 23C. Scattering data
were collected at sample-detector distances of 2m and 8m
for 900 s and 3600 s respectively. Transmission data were
collected at a sample-detector distance of 8m for 180 s. In
each case the collimation distance was equal to the
sample-detector distance.
SANS data were reduced in GRASansP v6.01 beta
(www.ill.fr/lss/grasp). Data were normalized to the
incident beam intensity and corrected for transmission,
cuvette thickness and detector efﬁciency. Scattering from
the sample holder and instrument background were then
subtracted and the data averaged radially around the
beam centre and normalized. Data collected at 2m and
8m sample-detector distances were then scaled and
merged in MS-EXCEL. The range of momentum
transfer sampled was 0.007< q< to 0.35 A˚1. The Rg
and I(0) values for each solute were extrapolated from a
Guinier plot of the very low angle scattering data in
PRIMUS and GNOM. Molecular masses of the
hydrogenated solutes were estimated using water
scattering as a reference (31,32).
Molecular modelling of Mos1 transposase
Low resolution protein structure models were reconstruc-
ted by ab initio simulated annealing, representing the
protein as a chain-like ensemble of dummy residues in
GASBOR (33). Ten models of Mos1 transposase were
generated in separate runs, and aligned pair-wise with
SUPCOMB (34) to compute the normalized spatial
discrepancy (NSD) between models. The quaternary
structure of Mos1 transposase was modelled with
SASREF (35) on the ATSAS server (http://www.embl-
hamburg.de/biosaxs/atsas-online). A dimeric arrangement
of subunits was constructed by simulated annealing using
the atomic structure of a transposase monomer from the
PEC crystal structure (PDB ID: 3HOT) and minimized
against the experiment SAXS data.
MONSA analysis
Low resolution models of the SEC2 complex were
calculated using MONSA (36) at the ATSAS server.
Five transposase–DNA complex data sets were included:
one SAXS data set of H-SEC2, and four SANS data sets
of H-SEC2 or D-SEC2 at different H2O:D2O ratios.
Contrasts for each component of the complex were
based on the isotopic composition of the sample for a
given D2O buffer composition (Supplementary Table S1).
RESULTS
H-Mos1 transposase structural parameters
SAXS data were collected from a solution of hydrogen-
ated transposase (H-Mos1) at 1.8mg/ml (Figure 2A), and
SANS data were collected from solutions of H-Mos1 in
100% H2O and 100% D2O (Figure 2B). By Guinier
analysis, the average radius of gyration (Rg) of the
transposase was 50.3±2.3 A˚ (Table 1). The molecular
weight of the H-Mos1 transposase was calculated to be
87.5±7.5 kDa, from the scattering intensity extrapolated
to zero angle (I(0)). This compares with a theoretical
molecular mass of the transposase monomer of
40.7 kDa. Thus the SAXS and SANS data conﬁrm that
Mos1 transposase is a dimer in solution, consistent with
previous conclusions from gel-ﬁltration analysis (11).
Nucleic Acids Research, 2013, Vol. 41, No. 3 2023
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The SAXS and SANS data were transformed using
GNOM into a distribution of paired distances, P(r), of
all inter-atomic vectors in H-Mos1; the P(r) distribution
calculated from the SAXS data is shown in Figure 2C. The
maximum dimension (Dmax) of the transposase dimer
was in the range 180–185 A˚ (Table 1).
SANS of D-Mos1 transposase
The use of deuterated transposase (D-Mos1) in neutron
scattering extends the range of contrasts available for
contrast variation experiments; proteins with 75%
deuterium incorporation are contrast matched in 100%
(v/v) D2O. We prepared partially deuterated D-Mos1 as
Figure 2. Small angle scattering of Mos1 transposase. (A) SAXS data of H-Mos1. (B) SANS of H-Mos1 in 100% H2O and 100% D2O. (C) Pair
distribution function, P(r), computed from the SAXS data. (D) SANS of D-Mos1 in 0, 30, 65 and 100% D2O.
Table 1. Structural parameters for Mos1 extracted from experimental SANS and SAXS data and the PEC crystal structure
Sample % D2O Conc (mg/ml) I(0) MW (kDa) Rg (A˚) Guinier Rg (A˚) Gnom Dmax (A˚)
SAXS H-Mos1 0 1.8 13.5 79.9 49.2±0.1 49.5±0.2 185
SANS H-Mos1 0 7.5 0.433 96.2 51.9±0.7 53.4±0.5 180
H-Mos1 100 8.8 0.913 89.5 51.2±0.4 55.9±0.2 180
SANS D-Mos1 0 1.1 0.38 86.4a 51.5±0.7 55.1±0.6 180
D-Mos1 30 1.1 0.15 51.1±1.5 53.7±0.9 180
D-Mos1 65 1.2 0.049 53.7±2.1 53.0±2.1 180
D-Mos1 100 1.2 0.01
Crystal Structure Mos1 81.3 38b 110
The coordinates for the Mos1 dimer in the PEC were extracted from the PDB ﬁle 3HOT.
aRenormalized for mass of H-Mos1.
bCaculated using CRYSOL.
2024 Nucleic Acids Research, 2013, Vol. 41, No. 3
 at Edinburgh U
niversity on M
ay 29, 2013
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
described in the methods. To determine experimentally the
contrast match point of the sample, and to conﬁrm its
integrity, we measured neutron scattering curves of
D-Mos1 in buffer containing 0, 30, 65 or 100% (v/v)
D2O (Figure 2D). The structural parameters Rg and
Dmax were consistent with those measured for H-Mos1
(Table 1). The scattering amplitude at zero angle was
calculated for each curve and plotted against the % D2O
content of the buffer (Supplementary Figure S1). The
linear best ﬁt to these points intercepted the x-axis at
92% (v/v) D2O, establishing the contrast match point
for D-Mos1.
Comparison of the DNA-free and PEC Mos1 dimers
We compared the experimentally measured structural
parameters Rg and Dmax for the H-Mos1 homodimer
in solution with those values calculated using the
crystallographic atomic coordinates of the transposase
dimer within the Mos1 PEC. Coordinates for all but the
N-terminal 3 residues of the sequence (which are likely to
be disordered) are deﬁned in the crystal structure. The
theoretical Rg for the compact and crossed arrangement
of the PEC dimer was 38 A˚ (compared with the measured
value of 50.3 A˚), and the Dmax was signiﬁcantly shorter at
110 A˚ (Table 1). A theoretical scattering curve for the
transposase was calculated with CRYSOL using the
crystallographic atomic coordinates (Supplementary
Figure S2A), but the agreement between the theoretical,
PEC model-based scattering curve and the experimentally
measured SAXS data was poor (=12.1). This indicates
that the conformation of the transposase dimer when free
in solution is signiﬁcantly different to that when bound to
two transposon DNA molecules in the PEC.
Shape of the Mos1 Dimer
Next we performed ab initio reconstruction of the shape of
the transposase dimer in solution from the SAXS data.
The protein was considered as a chain-like ensemble of
dummy residues in the program GASBOR (37), with no
symmetry restraints imposed. A gallery of 10 solutions are
shown in Figure 3A. Calculations were also performed
with P2 symmetry imposed and these gave similar results
(Supplementary Figure S3). The molecular envelopes each
have a markedly elongated, narrow shape, which contrasts
with the more compact, crossed architecture of the
transposase dimer in the Mos1 PEC (Figure 3B).
Relative orientation of domains
To establish how the monomers are arranged in the DNA-
free transposase homodimer, we modelled the elongated
quaternary structure by multi-subunit rigid body calcula-
tions. The atomic coordinates of a transposase monomer
from the PEC were used as the starting point. An
exhaustive grid search of homodimer conﬁgurations, and
their ﬁt to the experimental SAXS data, was performed.
To allow for potential variations in the orientations of
domains about ﬂexible linkers, the monomer structure
was split into three separate domains: HTH1 contained
residues Val 5 to Gly 56, HTH2 comprised residues Asp
57 to Gly 117 and the catalytic domain spanned Arg 118 to
Glu 345. Conditional distance restraints of 7 A˚ were deﬁned
between terminal residues of the three separated subunits
adjacent in the protein sequence.
Two possible models for the homodimer emerged from
this analysis, each ﬁtting reasonably to the SAXS curve. In
the ﬁrst tail-to-tail model, shown in Figure 3C, the two
catalytic domains are in contact at the centre of the
elongated homodimer, with the DNA-binding domains
distal from each other at the peripheries. This model
ﬁtted to the SAXS curve with =1.94 (Supplementary
Figure S2B). In the second head-to-head model, the
DNA-binding domains are in close proximity at the
centre of the homodimer (Figure 3D), with the HTH1
domains in contact. This model ﬁtted to the SAXS data
equally well, with =1.98 (Supplementary Figure S2C).
Head-to-tail models of the homodimer, in which the
DNA-binding domain of one monomer contacts the
catalytic domain of the second monomer (Figure 3E),
had signiﬁcantly lower quality ﬁts to the experimental
data, with =21.0 (Supplementary Figure S2D).
To distinguish between the tail-to-tail and head-to-head
models, we created deletion mutants of Mos1 transposase
(Figure 4A). We hypothesized that deletion of HTH1
would have little effect on transposase dimerization in
the tail-to-tail model of the elongated dimer (Figure 3C)
but would disrupt dimerization if the DNA-binding
domains were in contact, as in the head-to-head model
(Figure 3D). The converse would be true for mutants in
which the catalytic domain had been deleted.
A deletion mutant of Mos1 transposase lacking the
N-terminal 55 residues (delta-55 Mos1) was expressed
and puriﬁed (Figure 4B). Analysis by SEC-MALLS esta-
blished that delta-55 Mos1 eluted from the gel-ﬁltration
column after 30min with an average Mw of
33.7 kDa±2%, (Figure 4C). This mass corresponds to a
monomeric species. By comparison, the full-length
H-Mos1 homodimer eluted at 28.2min and had an
average Mw of 78.9 kDa±2%, consistent with a dimer.
Thus deletion of the N-terminal 55 residues (containing
HTH1) results in loss of transposase dimerization.
Next we performed the converse experiment. We
expressed and puriﬁed the DNA-binding domain of
Mos1, containing only the N-terminal 130 amino acids,
as described previously (29) (Figure 4B). SEC-MALLS
analysis showed that this deletion mutant eluted at
29.9min with a molecular mass of 32.7 kDa (Figure 4C)
and thus formed a dimer, like the full-length transposase.
A minor proportion of the sample (<1.5%) eluted after
only 26.1min and had a molecular mass of 68.3 kDa.
A silver-stained SDS-PAGE of the eluted fractions
conﬁrmed the minor component is a tetramer of trans-
posase (Supplementary Figure S4). Taken together these
results are consistent with the head-to-head model of the
Mos1 homodimer in which the DNA-binding domains are
at the centre of the elongated molecule, with the HTH1
domains in close contact as shown in Figure 3D.
Stoichiometry of the pre-cleavage single-end complex
Previously we proposed that Mos1 transposition is
initiated by a transposase dimer binding to the inverted
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repeat sequence at one transposon end (14), forming a
single-end complex (SEC2). This complex has been
observed by EMSA under non-catalytic conditions: for
example, when the Mg2+ ions required for PEC formation
and DNA cleavage are excluded from the reaction, or if
one of the catalytic Asp residues that coordinates Mg2+ is
mutated to Ala [Supplementary Figure S6 in ref (14)]. We
prepared a single-end complex (H-SEC2) by mixing
H-Mos1 with a 50 mer DNA duplex containing the
28 bp transposase inverted repeat recognition sequence
(as described in the methods). SEC-MALLS analysis
was performed to conﬁrm the homogeneity and
composition of H-SEC2. Samples of the DNA duplex
and H-Mos1 were also analysed separately as controls.
The SEC2 was loaded onto the gel-ﬁltration column at
an initial concentration of 7 mM, and eluted in a single
peak with an average molecular mass, measured by
MALLS, of 109.9 kDa±0.5% (Figure 5A). This is close
to the expected mass of 112 kDa for a complex containing
a dimer of transposase (81 kDa) and a single ds DNA
molecule (31 kDa). By comparison, the predicted mass
of SEC1 (transposase monomer bound to one DNA
duplex) is 71.4 kDa and the PEC (dimer bound to two
DNA molecules) is 143 kDa.
To conﬁrm the content and stoichiometry of the
complex, we analysed fractions of SEC2, eluted by gel-
ﬁltration chromatography, by SDS-PAGE silver-stained
for both protein and DNA (Figure 5B). We quantiﬁed
the number of pmoles of transposase and DNA seen in
each lane containing SEC2, by comparing the band
intensities with those of three internal protein controls
or three DNA controls, respectively. The molar ratio of
transposase to DNA in the complex was estimated to be
1.8, compared with a ratio of 2 expected for SEC2.
Further conﬁrmation of the stoichiometry of SEC2 was
obtained from the ratio of UV absorbance at 260 nm and
280 nm during gel-ﬁltration (Figure 5C). At the gel-
ﬁltration peak maximum this ratio was 1.50. We calculated
the theoretical UV absorbance ratios for SEC1, SEC2 and
PEC by summing the extinction coefﬁcients of the Mos1
and DNA components according to the stoichiometry of
each complex (Supplementary Table S2). The theoretical
absorbance ratios are 1.49 for SEC2 and 1.63 for both
SEC1 and the PEC. Thus the experimentally measured
ratio of 1.50 is consistent only with SEC2.
Solution scattering of SEC2 and contrast variation
To establish the solution conformation of the pre-cleavage
complex, we measured the small angle scattering from ﬁve
SEC2 samples, prepared with a 50 mer DNA duplex
(containing the 28 bp IR DNA sequence) and either
H-Mos1 or D-Mos1 (Table 2). A range of contrasts
between the components of the complex and the buffer
were used in the neutron scattering experiments to
enable the structural parameters, shape and relative
spatial arrangement of the protein and DNA to be
extracted. The use of deuterated transposase extended
the range of contrasts available and provided enhanced
scattering from the transposase, despite the lower
concentration available.
Figure 3. Solution conformations of Mos1 transposase. (A) Gallery of ten spherical bead models of the H-Mos1 dimer calculated from the SAXS
data in GASBOR, with no symmetry imposed. The  of the ﬁt to the experimental SAXS data and the NSD between models is indicated below each
model. (B) Compact structure of the Mos1 dimer in the PEC crystal structure (from PDB ID: 3HOT); one Mos1 monomer is blue and the other
orange. (C) An elongated tail-to-tail Mos1 dimer with a catalytic domain dimerization interface (C-C model). (D) Alternative elongated head-to-head
model with a DNA-binding domain interface (N-N model). (E) The elongated head-to-tail (N-C) model ﬁtted poorly to the scattering data.
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The scattering data collected are shown in Figure 6A. In
the SANS experiments, the relative contribution of each
component of the complex to the total scattering intensity
is dependent on the H2O:D2O ratio of the solvent in each
sample, as well as the deuteration level of the protein
(Supplementary Table S2). In particular, at 100% (v/v)
D2O solvent, the transposase component of D-SEC2 is
close to the contrast match point and the measured
scattering is dominated by the DNA component.
Conversely, at 65% (v/v) D2O solvent content, the DNA
is contrast matched and the measured scattering intensity
is primarily from the protein in the complex. The
scattering intensities measured from H-SEC2 in buffer
containing 0% (v/v) or 100% (v/v) D2O reﬂect the
parameters and conformation of the whole complex. We
also collected SAXS data on the H-SEC2 complex and in
this case the contrast of the DNA relative to the solvent
was twice that of the protein.
Figure 4. Analysis of Mos1 transposase deletion mutants. (A) Domain arrangements of full-length Mos1, the HTH1 domain deletion mutant delta-
55 Mos1 and the C-terminal deletion mutant N130 Mos1. (B) SDS-PAGE of puriﬁed transposases. The molecular weights of the markers are
indicated in kDa to the left of the gel and the mass by sequence of each sample is shown on the right of the gel. (C) SEC-MALLS analysis. The
scattering intensity (Rayleigh Ratio) is plotted against elution time of full-length Mos1, delta-55 Mos1 and N130 Mos1. The molar mass distribution
across each peak is shown in black.
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SEC2 model-independent structural parameters
We measured the molecular mass of H-SEC2 from the
SANS experiment in 100% (v/v) H2O, and the value of
109.2 kDa was in agreement with the mass measured by
SEC-MALLS. Consistent with this, the average Rg of
H-SEC2 was 60.4±0.8 A˚ (an increase from 50.3 A˚ for
the protein in the absence of DNA) and the average
Dmax was 220 A˚ (Figure 6B), suggesting that the
complex is 35–40 A˚ longer than the DNA-free
transposase dimer. From the scattering in 65% (v/v)
D2O, where the DNA is masked, the Rg of the transposase
within D-SEC2 was measured as 59.1±3.5 A˚. This is
larger than the Rg of the DNA-free transposase dimer
(53.7±2.1 A˚) and indicates that the protein conformation
has opened up upon binding DNA and forming SEC2.
This is also reﬂected by the larger Dmax of the transposase
in D-SEC2 (Figure 6C): 190 A˚ compared with 180 A˚ for the
DNA-free Mos1 dimer. From the scattering in 100%D2O,
the Dmax of the DNA was 125 A˚ (Figure 6D). This
compares with a Dmax of 140 A˚ and Rg of 40.2 A˚
Figure 5. Mass and stoichiometry of SEC2. (A) Elution proﬁle from SEC-MALLS. The scattering intensity (expressed as the Rayleigh ratio) is
plotted for SEC2, Mos1 and ds DNA. The average measured Mw for each sample is indicated in kDa, and the molar mass distribution across each
peak shown in black. The DNA duplex eluted earlier than the H-Mos1 dimer, despite its lower mass, due to its long and narrow shape. (B) Silver-
stained SDS-PAGE conﬁrms the stoichiometry of SEC2. Protein molecular weight markers (lane 1); internal standards containing 150, 300 and
450 ng of Mos1 transposase (lanes 2-4, respectively) or 50mer DNA (lanes 5–7, respectively); SEC2 gel-ﬁltration fractions (lanes 8–13). The number
of pmols of protein and DNA in each lane is shown below each lane. The molar ratio of Mos1 to DNA in SEC2 is also given below lanes 10–12.
(C) Gel-ﬁltration elution proﬁle of SEC2 monitored by UV absorption at 260 nm and 280 nm. The UV absorbance at the peak maximum is
307 mAU at 260 nm and 205 mAU at 280 nm. The SEC2 fractions are labelled across the peak in correspondence with the SDS-PAGE lane
numbers in (B).
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for the DNA duplex alone (SAXS data not shown). Taken
together these structural parameters indicate that the SEC2
has an elongated shape and that the transposase dimer has
a slightly more elongated conformation within the complex
than in its DNA-free state.
Next we used the Rg values for the complex and its
components to establish the placement of the DNA
relative to the transposase in H-SEC2. The distance
between the centres of mass of the transposase and
DNA can be related to the measured Rg values by the
parallel axes theorem (38), given by the equation:
Rg2ðSEC2Þ¼ xRg2ðMos1Þ+ð1 xÞRg2ðDNAÞ+xð1 xÞL2
where L is the distance in A˚ between the centres of mass of
the transposase and the DNA, and x is the fraction of total
scattering contributed from Mos1 transposase (38). The
Mos1 dimer contributes 80% of the volume of H-SEC2.
Because the protein has a contrast of 2.5 in 100% H2O
and the contrast of the DNA is 4.5, the fraction (x) of the
scattering from Mos1 is 0.69 (Supplementary Table S1).
Using the measured Rg values of the complex and its
protein and DNA components (58.1, 59.1 and 42.4 A˚,
respectively), the distance L is 44 A˚. Thus the centre of
the DNA is displaced from the transposase centre of mass
by a distance corresponding to approximately one ﬁfth of
the Dmax of the complex. This indicates that the DNA is
bound predominately to one half of the transposase dimer.
Conformation of the pre-cleavage complex
Next we used multi-phase analysis of the scattering curves,
collected at the different phase contrasts, to calculate a
low-resolution envelope for the whole complex in which
the transposase and DNA components are also distin-
guished. A gallery of the average bead models from
eight separate simulations, performed using MONSA, is
shown in Figure 6E. Models were aligned to each other
using DAMAVER and the NSD is indicated below each
model. The DNA phase has a long narrow shape
consistent with the conformation of linear B-form DNA
and is localized predominantly to one half of the complex.
A B-form DNA duplex of 50 nucleotides can be
superimposed on this phase (Figure 7). The transposase
phase adopts an elongated conformation which is
extended compared with the DNA-free Mos1 dimer,
with a small dimerization interface. Two monomers of
Mos1 can ﬁt into the envelope (ﬁtting performed by eye)
so that the DNA is predominantly associated with one
monomer, while the other monomer is presumed to be
more ﬂexible.
DISCUSSION
Cut-and-paste DNA transposition is orchestrated by
transposase, which promotes the DNA cleavage and
joining reactions. The initial steps of Mos1 transposition
involve sequence-speciﬁc binding of transposase to the
inverted repeat sequences at the transposon ends. Full
excision of the transposon from the donor site occurs
only after the two ends are brought together in a PEC
containing a transposase dimer. To investigate how the
PEC may form, we have established the stoichiometry
and low resolution conformations of the early
intermediates in the pathway: that is, the DNA-free full-
length transposase and the pre-cleavage complex of
transposase and a single transposon end (SEC2).
Using solution scattering techniques, we have conﬁrmed
that the transposase is a homodimer in solution without
DNA and established that it adopts an extended
conformation. This arrangement differs markedly from
the more compact, crossed architecture of the dimer
when bound to two pre-cleaved DNA molecules in the
PEC crystal structure. The elongation is reﬂected by the
larger measured radius of gyration (50 A˚) and maximum
dimension (180 A˚) of the transposase dimer in solution
compared with values calculated for the protein
component of the PEC (Rg=38 A˚ and Dmax=110 A˚).
These results suggest that the transposase dimer changes
conformation prior to PEC formation, either upon
binding to one transposon DNA end or during the
synapsis of the two ends.
To establish how the transposase domains are arranged
within the elongated dimer, and which domains are
essential for transposase dimerization in the absence of
DNA, we prepared deletion mutants of Mos1 transposase.
These lacked either the N-terminal 55 amino acids
(containing HTH1) or the C-terminal catalytic domain.
We found that the transposase was a monomer when the
N-terminal 55 residues were deleted, whereas the mutant
lacking the catalytic domain could still form dimers in
solution. The elongated transposase dimer is therefore
likely to be arranged with the DNA-binding domain at
the central interface (as proposed in Figure 3D). An
alternative model in which the catalytic domains interact
and the DNA-binding domains extend to the dimer
peripheries is not consistent with these results and is
discounted.
Table 2. Analysis of SANS and SAXS data of transposase–DNA single-end complexes
Sample % D2O Conc (mg/ml) I(0) MW Rg (A˚) Guinier Rg (A˚) GNOM Dmax (GNOM) (A˚)  ﬁt to data MONSA
SAXS
H-SEC2 0 2.3 0.53 57.8±3.5 62.5±2.1 220 0.74
SANS
H-SEC2 0 4.3 0.38 109.2 58.1±0.7 60.1±0.8 220 2.03
H-SEC2 100 2.6 0.22 105.6 58.2±0.5 60.6±0.5 220 2.41
D-SEC2 65 1.3 0.051 59.1±3.5 60.37±2.2 190 2.18
D-SEC2 100 1.4 0.009 42.4±3.9 40.8±0.4 125 0.85
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Transposase dimerization via the N-terminal 55
residues may be a molecular feature that is maintained
throughout the Mos1 transposition pathway. In the PEC
structure (14), this domain establishes a hydrophobic
dimerization interface as well as binding sequence
speciﬁcally to the inner 8 bp of IR DNA, via the HTH1
motif. The N-terminal 30 residues are essential for
sequence-speciﬁc IR DNA binding (12,29), and deletion
of the ﬁrst 34 or 50 residues resulted in the loss of
transposition activity in a plasmid-based transposition
assay in E. coli (18). Weak transposition activity was
regained, however, when the ﬁrst 34 residues were
replaced by either the dimerization domain of Gal4 or a
leucine zipper dimerization domain (18). Taken together
these data suggest that sequence-speciﬁc interaction of the
HTH1 motif with IR DNA is not vital for Mos1
Figure 6. Small angle scattering and solution conformations of SEC2. (A) SAXS and SANS data of SEC2 complexes prepared with H-Mos1 and
D-Mos1. (B) Pair distribution functions, P(r), of H-SEC2 complexes measured by SAXS (black) and SANS in 0% D2O (green) and SANS in 100%
D2O (purple). The Dmax reﬂects the maximum dimension of the complex. (C) P(r) of D-SEC2 in 65% D2O reﬂects the shape and Dmax of the
protein component of the complex only (DNA contrast matched). (D) P(r) of D-SEC2 at 100% D2O is dominated by the contribution from DNA.
(E) Gallery of 8 bead models of SEC2 generated using MONSA, containing a DNA phase (green) and the protein phase (grey). Models were aligned
in DAMAVER and the NSD for each model is indicated.
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transposition, whereas transposase dimerization via the
N-terminal residues is required.
Oligomerization prior to sequence-speciﬁc DNA
binding has been observed for other eukaryotic DNA
transposases, and may be a general feature regulating
early steps in eukaryotic transposition. The P element
transposase from Drosophila melanogaster exists as a
pre-formed tetramer that binds to one of the two P
element ends (9). The core RAG1 recombinase is either
a dimer or trimer and associates with two RAG2 subunits
to assemble on one recombination signal sequence, as a
hetero-oligomer, before synapsis (39,40). The
N-terminally truncated hAT transposase Hermes, from
Musca domestica, exists as a hexamer both in solution
and in crystals (41). In the mariner/Tc1 family, the
N-terminal 57 amino acids of Sleeping Beauty transposase
have been implicated in tetramerization of the DNA-
binding domain in complex with transposase-binding
sites (42), and the N-terminal region of Himar1 is
involved in a protein–protein interaction interface (43).
By contrast, the bacterial Tn5 transposase is most likely
a monomer when not bound to DNA (44). It is thought
that a conformational change in the free transposase
monomer could allow for DNA binding and transposase
dimerization (45) in the context of the synaptic complex
containing two transposon ends (46).
Mos1 transposition is initiated by sequence-speciﬁc
binding of transposase to a transposon end. Here we
used SEC-MALLS, small angle scattering, gel analysis
and UV absorbance measurements to establish that the
in vitro single-end complex contains a transposase dimer
bound to one transposon DNA duplex. Using contrast
variation neutron scattering experiments, we measured
the structural parameters Rg and Dmax for the complex
and its two constituent molecules. These revealed model-
independent information about the shape, dimensions and
relative spatial arrangement of the transposase and DNA
in SEC2. We found that, like the transposase dimer, SEC2
has an elongated architecture, but the transposase in the
complex has become slightly more extended upon binding
DNA. The dimensions of the DNA phase within SEC2 are
consistent with a linear B-form DNA duplex, and the 51 A˚
separation between the centres of mass of the DNA and
transposase suggests that the DNA is bound predomi-
nantly to one half of the transposase dimer.
The low resolution structural models of the SEC2 in
solution illustrate the elongated shape and the relative
spatial arrangement of the transposase and DNA within
Figure 7. Schematic mechanism of early steps in Mos1 transposition. Transposase (blue and orange monomers) exits as an elongated dimer in
solution with the N-terminal domains at the central dimerization interface. When bound to one IR DNA in SEC2, the transposase dimer becomes
more extended and the DNA (green) is predominantly associated with one monomer (blue); the other monomer (orange) may be more ﬂexible. The
phase model was interpreted by docking Mos1 monomers (ribbon) by eye to the protein phase and a 50 mer DNA duplex (green surface) to the
DNA phase. The PEC could form by rotation of the ﬂexible monomer about the HTH1 domain, accompanied by binding of the second transposon
end. There may also be exchange of DNA between the two catalytic domains. Solution structures of the Mos1 dimer and SEC2, and the PEC crystal
structure (3HOT) are shown below the schematic.
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the complex. As predicted from analysis of the structural
parameters, the DNA phase is seen to associate primarily
with one half of the transposase dimer; the other half of
the protein phase has fewer contacts with the DNA and is
presumed to have more conformational freedom. The
similarities in the architectures of the transposase in
SEC2 and in solution suggest that binding of the pre-
formed transposase dimer to the ﬁrst transposon end
occurs without major conformational changes in either
the protein or the IR DNA.
Comparison of the solution conformations of SEC2 and
the PEC crystal structure suggests that a major
conformational change in the transposase would occur
during a transition from SEC2 to PEC. The data and
models presented here provide a basis to propose a
mechanism for this conformational change. We speculate
that the transposase transitions from the elongated open
dimer form when bound to one transposon end to the
more closed compact arrangement seen in the PEC, by
rotation of one monomer of transposase by 180 with
respect to the other. The N-terminal 55 residues of the
DNA-binding domain may be the pivot for this
rotation. As depicted in Figure 7, rotation of the free
half of the transposase dimer about the DNA-binding
domain could promote rearrangement of the complex.
This rotation may be in concert with or triggered by
binding of a second transposon DNA end, which would
promote DNA looping.
One controversial issue regarding the Mos1
transposition mechanism remains outstanding: does
nicking of the ﬁrst DNA strand occur before or after
synapsis of the Mos1 transposon ends? Dawson and
Finnegan (10) reported that ﬁrst strand cleavage was not
dependent on prior PEC formation. Similarly, catalysis of
Himar1 without synapsis of the ends was reported (16).
Nicking of one strand prior to PEC formation could
trigger a conformational change in SEC2, which then
facilitates pairing of the two ends. This could provide
one molecular explanation for metal ion dependence of
PEC formation.
The SEC2 to PEC model raises questions about how the
crossed (or trans) arrangement of transposase and IR
DNA observed in the PEC could arise. The modular
nature of the transposase, with long ﬂexible linkers
between the DNA-binding and catalytic domains, could
allow for sub-unit exchange from one IR DNA molecule
to the other, during major conformational changes in the
transposase. However, it remains to be established
whether this exchange occurs before or after PEC
formation or between cleavage events.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online:
Supplementary Tables 1–2 and Supplementary Figures
1–4.
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